| 1 | GNAQ, PLCB2, SNCG
|
| γ-Synuclein interacts with phospholipase Cβ2 to modulate G protein activation.
|
| Golebiewska U, Guo Y, Khalikaprasad N, Zurawsky C, Yerramilli VS, Scarlata S.
|
| PLoS One 7(8):e41067. doi: 10.1371/journal.pone.0041067. Epub 2012 Aug 8.
2012
|
| 2 | SNCG
|
| Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
|
| Hibi T, Mori T, Fukuma M, Yamazaki K, Hashiguchi A, Yamada T, Tanabe M, Aiura K, Kawakami T, Ogiwara A, Kosuge T, Kitajima M, Kitagawa Y, Sakamoto M.
|
| Clin Cancer Res 15(8):2864-71. Epub 2009 Apr 7.PMID: 19351749 2009
|
| 3 | SNCG
|
| Gamma-synuclein as a marker of retinal ganglion cells.
|
| Surgucheva I, Weisman AD, Goldberg JL, Shnyra A, Surguchov A.
|
| Mol Vis 14:1540-8.PMID: 18728752 2008
|
| 4 | SNCG
|
| Gamma-synuclein: cell-type-specific promoter activity and binding to transcription factors.
|
| Surgucheva I, Surguchov A.
|
| J Mol Neurosci 35(3):267-71. Epub 2008 May 23.PMID: 18498014 2008
|
| 5 | SNCG
|
| Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.
|
| Guo J, Shou C, Meng L, Jiang B, Dong B, Yao L, Xie Y, Zhang J, Chen Y, Budman DR, Shi YE.
|
| Int J Cancer 121(6):1296-305.PMID: 17534899 2007
|
| 6 | SNCG
|
| The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
|
| Czekierdowski A, Czekierdowska S, Wielgos M, Smolen A, Kaminski P, Kotarski J.
|
| Neuro Endocrinol Lett 27(3):381-6. 2006
|
| 7 | SNCG
|
| Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.
|
| Zhao W, Liu H, Liu W, Wu Y, Chen W, Jiang B, Zhou Y, Xue R, Luo C, Wang L, Jiang JD, Liu J.
|
| Int J Oncol 28(5):1081-8. 2006
|
| 8 | SNCG
|
| Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects.
|
| Li QX, Campbell BC, McLean CA, Thyagarajan D, Gai WP, Kapsa RM, Beyreuther K, Masters CL, Culvenor JG.
|
| J Alzheimers Dis 4(4):309-15. 2002
|
| 9 | SNCA, SNCB, SNCG
|
| Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
|
| Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK.
|
| Cancer 88(9):2154-63. 2000
|
| 10 | SNCG
|
| Mutations in the gene encoding human persyn are not associated with amyotrophic lateral sclerosis or familial Parkinson's disease.
|
| Flowers JM, Leigh PN, Davies AM, Ninkina NN, Buchman VL, Vaughan J, Wood NW, Powell JF.
|
| Neurosci Lett 274(1):21-4 1999
|
| 11 | SNCG
|
| Identification, localization and characterization of the human gamma-synuclein gene.
|
| Lavedan C, et al.
|
| Hum Genet 103 : 106-112. 1998
|
| 12 | SNCG
|
| Organization, expression and polymorphism of the human persyn gene.
|
| Ninkina NN, Alimova-Kost MV, Paterson JW, Delaney L, Cohen BB, Imreh S, Gnuchev NV, Davies AM, Buchman VL.
|
| Hum Mol Genet 7 : 1417-1424. 1998
|
| 13 | SNCG
|
| Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system.
|
| Buchman VL, Hunter HJ, Pinon LG, Thompson J, Privalova EM, Ninkina NN, Davies AM.
|
| J Neurosci 18 : 9335-9341. 1998
|
| 14 | SNCA, SNCB, SNCG
|
| The synuclein family.
|
| Lavedan C.
|
| Genome Res 8(9):871-80. Review. 1998
|
| 15 | SNCG
|
| Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
|
| Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE.
|
| Cancer Res 57 : 759-764. 1997
|